Global Antiviral Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Antiviral Drugs market size was valued at USD 1638 million in 2023 and is forecast to a readjusted size of USD 2243.1 million by 2030 with a CAGR of 4.6% during review period.
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
The Global Info Research report includes an overview of the development of the Antiviral Drugs industry chain, the market status of Hepatitis Therapeutics (Reverse Transcriptase Inhibitors, Protease Inhibitors), HIV/AIDS Therapeutics (Reverse Transcriptase Inhibitors, Protease Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiviral Drugs.
Regionally, the report analyzes the Antiviral Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiviral Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antiviral Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiviral Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Reverse Transcriptase Inhibitors, Protease Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiviral Drugs market.
Regional Analysis: The report involves examining the Antiviral Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiviral Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antiviral Drugs:
Company Analysis: Report covers individual Antiviral Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiviral Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hepatitis Therapeutics, HIV/AIDS Therapeutics).
Technology Analysis: Report covers specific technologies relevant to Antiviral Drugs. It assesses the current state, advancements, and potential future developments in Antiviral Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiviral Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antiviral Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Antiviral Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antiviral Drugs, with price, sales, revenue and global market share of Antiviral Drugs from 2019 to 2024.
Chapter 3, the Antiviral Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiviral Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antiviral Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antiviral Drugs.
Chapter 14 and 15, to describe Antiviral Drugs sales channel, distributors, customers, research findings and conclusion.
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
The Global Info Research report includes an overview of the development of the Antiviral Drugs industry chain, the market status of Hepatitis Therapeutics (Reverse Transcriptase Inhibitors, Protease Inhibitors), HIV/AIDS Therapeutics (Reverse Transcriptase Inhibitors, Protease Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiviral Drugs.
Regionally, the report analyzes the Antiviral Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiviral Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antiviral Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiviral Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Reverse Transcriptase Inhibitors, Protease Inhibitors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiviral Drugs market.
Regional Analysis: The report involves examining the Antiviral Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiviral Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antiviral Drugs:
Company Analysis: Report covers individual Antiviral Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiviral Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hepatitis Therapeutics, HIV/AIDS Therapeutics).
Technology Analysis: Report covers specific technologies relevant to Antiviral Drugs. It assesses the current state, advancements, and potential future developments in Antiviral Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiviral Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antiviral Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Fusion Inhibitors
- Immune System Modulators
- Hepatitis Therapeutics
- HIV/AIDS Therapeutics
- Herpes Therapeutics
- Influenza Therapeutics
- Roche
- Johnson & Johnson
- Merck
- Novartis
- Bristol-Myers Squibb
- Gilead Sciences
- GlaxoSmithKline
- AbbVie
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Antiviral Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antiviral Drugs, with price, sales, revenue and global market share of Antiviral Drugs from 2019 to 2024.
Chapter 3, the Antiviral Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiviral Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Antiviral Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antiviral Drugs.
Chapter 14 and 15, to describe Antiviral Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Antiviral Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antiviral Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Reverse Transcriptase Inhibitors
1.3.3 Protease Inhibitors
1.3.4 Fusion Inhibitors
1.3.5 Immune System Modulators
1.4 Market Analysis by Application
1.4.1 Overview: Global Antiviral Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hepatitis Therapeutics
1.4.3 HIV/AIDS Therapeutics
1.4.4 Herpes Therapeutics
1.4.5 Influenza Therapeutics
1.5 Global Antiviral Drugs Market Size & Forecast
1.5.1 Global Antiviral Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Antiviral Drugs Sales Quantity (2019-2030)
1.5.3 Global Antiviral Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antiviral Drugs Product and Services
2.1.4 Roche Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Antiviral Drugs Product and Services
2.2.4 Johnson & Johnson Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antiviral Drugs Product and Services
2.3.4 Merck Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Antiviral Drugs Product and Services
2.4.4 Novartis Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments/Updates
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Antiviral Drugs Product and Services
2.5.4 Bristol-Myers Squibb Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bristol-Myers Squibb Recent Developments/Updates
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business
2.6.3 Gilead Sciences Antiviral Drugs Product and Services
2.6.4 Gilead Sciences Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gilead Sciences Recent Developments/Updates
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Antiviral Drugs Product and Services
2.7.4 GlaxoSmithKline Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GlaxoSmithKline Recent Developments/Updates
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Antiviral Drugs Product and Services
2.8.4 AbbVie Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AbbVie Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIVIRAL DRUGS BY MANUFACTURER
3.1 Global Antiviral Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Antiviral Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Antiviral Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Antiviral Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Antiviral Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Antiviral Drugs Manufacturer Market Share in 2023
3.5 Antiviral Drugs Market: Overall Company Footprint Analysis
3.5.1 Antiviral Drugs Market: Region Footprint
3.5.2 Antiviral Drugs Market: Company Product Type Footprint
3.5.3 Antiviral Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antiviral Drugs Market Size by Region
4.1.1 Global Antiviral Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Antiviral Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Antiviral Drugs Average Price by Region (2019-2030)
4.2 North America Antiviral Drugs Consumption Value (2019-2030)
4.3 Europe Antiviral Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Antiviral Drugs Consumption Value (2019-2030)
4.5 South America Antiviral Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Antiviral Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Antiviral Drugs Sales Quantity by Type (2019-2030)
5.2 Global Antiviral Drugs Consumption Value by Type (2019-2030)
5.3 Global Antiviral Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antiviral Drugs Sales Quantity by Application (2019-2030)
6.2 Global Antiviral Drugs Consumption Value by Application (2019-2030)
6.3 Global Antiviral Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Antiviral Drugs Sales Quantity by Type (2019-2030)
7.2 North America Antiviral Drugs Sales Quantity by Application (2019-2030)
7.3 North America Antiviral Drugs Market Size by Country
7.3.1 North America Antiviral Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Antiviral Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Antiviral Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Antiviral Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Antiviral Drugs Market Size by Country
8.3.1 Europe Antiviral Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Antiviral Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antiviral Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Antiviral Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Antiviral Drugs Market Size by Region
9.3.1 Asia-Pacific Antiviral Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Antiviral Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Antiviral Drugs Sales Quantity by Type (2019-2030)
10.2 South America Antiviral Drugs Sales Quantity by Application (2019-2030)
10.3 South America Antiviral Drugs Market Size by Country
10.3.1 South America Antiviral Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Antiviral Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antiviral Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Antiviral Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Antiviral Drugs Market Size by Country
11.3.1 Middle East & Africa Antiviral Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Antiviral Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Antiviral Drugs Market Drivers
12.2 Antiviral Drugs Market Restraints
12.3 Antiviral Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antiviral Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antiviral Drugs
13.3 Antiviral Drugs Production Process
13.4 Antiviral Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antiviral Drugs Typical Distributors
14.3 Antiviral Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Antiviral Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antiviral Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Reverse Transcriptase Inhibitors
1.3.3 Protease Inhibitors
1.3.4 Fusion Inhibitors
1.3.5 Immune System Modulators
1.4 Market Analysis by Application
1.4.1 Overview: Global Antiviral Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hepatitis Therapeutics
1.4.3 HIV/AIDS Therapeutics
1.4.4 Herpes Therapeutics
1.4.5 Influenza Therapeutics
1.5 Global Antiviral Drugs Market Size & Forecast
1.5.1 Global Antiviral Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Antiviral Drugs Sales Quantity (2019-2030)
1.5.3 Global Antiviral Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Antiviral Drugs Product and Services
2.1.4 Roche Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Antiviral Drugs Product and Services
2.2.4 Johnson & Johnson Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Antiviral Drugs Product and Services
2.3.4 Merck Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Antiviral Drugs Product and Services
2.4.4 Novartis Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments/Updates
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Antiviral Drugs Product and Services
2.5.4 Bristol-Myers Squibb Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bristol-Myers Squibb Recent Developments/Updates
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business
2.6.3 Gilead Sciences Antiviral Drugs Product and Services
2.6.4 Gilead Sciences Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Gilead Sciences Recent Developments/Updates
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Antiviral Drugs Product and Services
2.7.4 GlaxoSmithKline Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GlaxoSmithKline Recent Developments/Updates
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Antiviral Drugs Product and Services
2.8.4 AbbVie Antiviral Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 AbbVie Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIVIRAL DRUGS BY MANUFACTURER
3.1 Global Antiviral Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Antiviral Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Antiviral Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Antiviral Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Antiviral Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Antiviral Drugs Manufacturer Market Share in 2023
3.5 Antiviral Drugs Market: Overall Company Footprint Analysis
3.5.1 Antiviral Drugs Market: Region Footprint
3.5.2 Antiviral Drugs Market: Company Product Type Footprint
3.5.3 Antiviral Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antiviral Drugs Market Size by Region
4.1.1 Global Antiviral Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Antiviral Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Antiviral Drugs Average Price by Region (2019-2030)
4.2 North America Antiviral Drugs Consumption Value (2019-2030)
4.3 Europe Antiviral Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Antiviral Drugs Consumption Value (2019-2030)
4.5 South America Antiviral Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Antiviral Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Antiviral Drugs Sales Quantity by Type (2019-2030)
5.2 Global Antiviral Drugs Consumption Value by Type (2019-2030)
5.3 Global Antiviral Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antiviral Drugs Sales Quantity by Application (2019-2030)
6.2 Global Antiviral Drugs Consumption Value by Application (2019-2030)
6.3 Global Antiviral Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Antiviral Drugs Sales Quantity by Type (2019-2030)
7.2 North America Antiviral Drugs Sales Quantity by Application (2019-2030)
7.3 North America Antiviral Drugs Market Size by Country
7.3.1 North America Antiviral Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Antiviral Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Antiviral Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Antiviral Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Antiviral Drugs Market Size by Country
8.3.1 Europe Antiviral Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Antiviral Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antiviral Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Antiviral Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Antiviral Drugs Market Size by Region
9.3.1 Asia-Pacific Antiviral Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Antiviral Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Antiviral Drugs Sales Quantity by Type (2019-2030)
10.2 South America Antiviral Drugs Sales Quantity by Application (2019-2030)
10.3 South America Antiviral Drugs Market Size by Country
10.3.1 South America Antiviral Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Antiviral Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antiviral Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Antiviral Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Antiviral Drugs Market Size by Country
11.3.1 Middle East & Africa Antiviral Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Antiviral Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Antiviral Drugs Market Drivers
12.2 Antiviral Drugs Market Restraints
12.3 Antiviral Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antiviral Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antiviral Drugs
13.3 Antiviral Drugs Production Process
13.4 Antiviral Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antiviral Drugs Typical Distributors
14.3 Antiviral Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Antiviral Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antiviral Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Antiviral Drugs Product and Services
Table 6. Roche Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Antiviral Drugs Product and Services
Table 11. Johnson & Johnson Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Antiviral Drugs Product and Services
Table 16. Merck Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Antiviral Drugs Product and Services
Table 21. Novartis Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis Recent Developments/Updates
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb Antiviral Drugs Product and Services
Table 26. Bristol-Myers Squibb Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bristol-Myers Squibb Recent Developments/Updates
Table 28. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 29. Gilead Sciences Major Business
Table 30. Gilead Sciences Antiviral Drugs Product and Services
Table 31. Gilead Sciences Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Gilead Sciences Recent Developments/Updates
Table 33. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 34. GlaxoSmithKline Major Business
Table 35. GlaxoSmithKline Antiviral Drugs Product and Services
Table 36. GlaxoSmithKline Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GlaxoSmithKline Recent Developments/Updates
Table 38. AbbVie Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie Major Business
Table 40. AbbVie Antiviral Drugs Product and Services
Table 41. AbbVie Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AbbVie Recent Developments/Updates
Table 43. Global Antiviral Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 44. Global Antiviral Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Antiviral Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 46. Market Position of Manufacturers in Antiviral Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Antiviral Drugs Production Site of Key Manufacturer
Table 48. Antiviral Drugs Market: Company Product Type Footprint
Table 49. Antiviral Drugs Market: Company Product Application Footprint
Table 50. Antiviral Drugs New Market Entrants and Barriers to Market Entry
Table 51. Antiviral Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Antiviral Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 53. Global Antiviral Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 54. Global Antiviral Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Antiviral Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Antiviral Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 57. Global Antiviral Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 58. Global Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Global Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Global Antiviral Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Antiviral Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Antiviral Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 63. Global Antiviral Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 64. Global Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 65. Global Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 66. Global Antiviral Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Antiviral Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Antiviral Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 69. Global Antiviral Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 70. North America Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 71. North America Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 72. North America Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 73. North America Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 74. North America Antiviral Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 75. North America Antiviral Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 76. North America Antiviral Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Antiviral Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Europe Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Europe Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Europe Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Europe Antiviral Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 83. Europe Antiviral Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 84. Europe Antiviral Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Antiviral Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 87. Asia-Pacific Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 88. Asia-Pacific Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 89. Asia-Pacific Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 90. Asia-Pacific Antiviral Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 91. Asia-Pacific Antiviral Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 92. Asia-Pacific Antiviral Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Antiviral Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 95. South America Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 96. South America Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 97. South America Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 98. South America Antiviral Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 99. South America Antiviral Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 100. South America Antiviral Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Antiviral Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Middle East & Africa Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Middle East & Africa Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Middle East & Africa Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Middle East & Africa Antiviral Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Middle East & Africa Antiviral Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Middle East & Africa Antiviral Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Antiviral Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Antiviral Drugs Raw Material
Table 111. Key Manufacturers of Antiviral Drugs Raw Materials
Table 112. Antiviral Drugs Typical Distributors
Table 113. Antiviral Drugs Typical Customers
Table 1. Global Antiviral Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antiviral Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Antiviral Drugs Product and Services
Table 6. Roche Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Antiviral Drugs Product and Services
Table 11. Johnson & Johnson Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Antiviral Drugs Product and Services
Table 16. Merck Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Antiviral Drugs Product and Services
Table 21. Novartis Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis Recent Developments/Updates
Table 23. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb Major Business
Table 25. Bristol-Myers Squibb Antiviral Drugs Product and Services
Table 26. Bristol-Myers Squibb Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bristol-Myers Squibb Recent Developments/Updates
Table 28. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 29. Gilead Sciences Major Business
Table 30. Gilead Sciences Antiviral Drugs Product and Services
Table 31. Gilead Sciences Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Gilead Sciences Recent Developments/Updates
Table 33. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 34. GlaxoSmithKline Major Business
Table 35. GlaxoSmithKline Antiviral Drugs Product and Services
Table 36. GlaxoSmithKline Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. GlaxoSmithKline Recent Developments/Updates
Table 38. AbbVie Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie Major Business
Table 40. AbbVie Antiviral Drugs Product and Services
Table 41. AbbVie Antiviral Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. AbbVie Recent Developments/Updates
Table 43. Global Antiviral Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 44. Global Antiviral Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Antiviral Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 46. Market Position of Manufacturers in Antiviral Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Antiviral Drugs Production Site of Key Manufacturer
Table 48. Antiviral Drugs Market: Company Product Type Footprint
Table 49. Antiviral Drugs Market: Company Product Application Footprint
Table 50. Antiviral Drugs New Market Entrants and Barriers to Market Entry
Table 51. Antiviral Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Antiviral Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 53. Global Antiviral Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 54. Global Antiviral Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Antiviral Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Antiviral Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 57. Global Antiviral Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 58. Global Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Global Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Global Antiviral Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Antiviral Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Antiviral Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 63. Global Antiviral Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 64. Global Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 65. Global Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 66. Global Antiviral Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Antiviral Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Antiviral Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 69. Global Antiviral Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 70. North America Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 71. North America Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 72. North America Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 73. North America Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 74. North America Antiviral Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 75. North America Antiviral Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 76. North America Antiviral Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Antiviral Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Europe Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Europe Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Europe Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Europe Antiviral Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 83. Europe Antiviral Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 84. Europe Antiviral Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Antiviral Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 87. Asia-Pacific Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 88. Asia-Pacific Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 89. Asia-Pacific Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 90. Asia-Pacific Antiviral Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 91. Asia-Pacific Antiviral Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 92. Asia-Pacific Antiviral Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Antiviral Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 95. South America Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 96. South America Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 97. South America Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 98. South America Antiviral Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 99. South America Antiviral Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 100. South America Antiviral Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Antiviral Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Antiviral Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Middle East & Africa Antiviral Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Middle East & Africa Antiviral Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Middle East & Africa Antiviral Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Middle East & Africa Antiviral Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Middle East & Africa Antiviral Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Middle East & Africa Antiviral Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Antiviral Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Antiviral Drugs Raw Material
Table 111. Key Manufacturers of Antiviral Drugs Raw Materials
Table 112. Antiviral Drugs Typical Distributors
Table 113. Antiviral Drugs Typical Customers
LIST OF FIGURES
Figure 1. Antiviral Drugs Picture
Figure 2. Global Antiviral Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antiviral Drugs Consumption Value Market Share by Type in 2023
Figure 4. Reverse Transcriptase Inhibitors Examples
Figure 5. Protease Inhibitors Examples
Figure 6. Fusion Inhibitors Examples
Figure 7. Immune System Modulators Examples
Figure 8. Global Antiviral Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Antiviral Drugs Consumption Value Market Share by Application in 2023
Figure 10. Hepatitis Therapeutics Examples
Figure 11. HIV/AIDS Therapeutics Examples
Figure 12. Herpes Therapeutics Examples
Figure 13. Influenza Therapeutics Examples
Figure 14. Global Antiviral Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Antiviral Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Antiviral Drugs Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Antiviral Drugs Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Antiviral Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Antiviral Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Antiviral Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Antiviral Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Antiviral Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Antiviral Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Antiviral Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Antiviral Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Antiviral Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Antiviral Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Antiviral Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Antiviral Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Antiviral Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Antiviral Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Antiviral Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Antiviral Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Antiviral Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Antiviral Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Antiviral Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Antiviral Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Antiviral Drugs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Antiviral Drugs Market Drivers
Figure 77. Antiviral Drugs Market Restraints
Figure 78. Antiviral Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Antiviral Drugs in 2023
Figure 81. Manufacturing Process Analysis of Antiviral Drugs
Figure 82. Antiviral Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Antiviral Drugs Picture
Figure 2. Global Antiviral Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antiviral Drugs Consumption Value Market Share by Type in 2023
Figure 4. Reverse Transcriptase Inhibitors Examples
Figure 5. Protease Inhibitors Examples
Figure 6. Fusion Inhibitors Examples
Figure 7. Immune System Modulators Examples
Figure 8. Global Antiviral Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Antiviral Drugs Consumption Value Market Share by Application in 2023
Figure 10. Hepatitis Therapeutics Examples
Figure 11. HIV/AIDS Therapeutics Examples
Figure 12. Herpes Therapeutics Examples
Figure 13. Influenza Therapeutics Examples
Figure 14. Global Antiviral Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Antiviral Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Antiviral Drugs Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Antiviral Drugs Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Antiviral Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Antiviral Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Antiviral Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Antiviral Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Antiviral Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Antiviral Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Antiviral Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Antiviral Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Antiviral Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Antiviral Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Antiviral Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Antiviral Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Antiviral Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Antiviral Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Antiviral Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Antiviral Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Antiviral Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Antiviral Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Antiviral Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Antiviral Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Antiviral Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Antiviral Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Antiviral Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Antiviral Drugs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Antiviral Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Antiviral Drugs Market Drivers
Figure 77. Antiviral Drugs Market Restraints
Figure 78. Antiviral Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Antiviral Drugs in 2023
Figure 81. Manufacturing Process Analysis of Antiviral Drugs
Figure 82. Antiviral Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
